175 related articles for article (PubMed ID: 37364760)
1. Gut mycobiome in metabolic diseases: Mechanisms and clinical implication.
Zhou X; Zhang X; Yu J
Biomed J; 2023 Jun; ():100625. PubMed ID: 37364760
[TBL] [Abstract][Full Text] [Related]
2. Gut mycobiome and metabolic diseases: The known, the unknown, and the future.
Wang L; Zhang K; Zeng Y; Luo Y; Peng J; Zhang J; Kuang T; Fan G
Pharmacol Res; 2023 Jul; 193():106807. PubMed ID: 37244385
[TBL] [Abstract][Full Text] [Related]
3. The fecal mycobiome in non-alcoholic fatty liver disease.
Demir M; Lang S; Hartmann P; Duan Y; Martin A; Miyamoto Y; Bondareva M; Zhang X; Wang Y; Kasper P; Bang C; Roderburg C; Tacke F; Steffen HM; Goeser T; Kruglov A; Eckmann L; Stärkel P; Fouts DE; Schnabl B
J Hepatol; 2022 Apr; 76(4):788-799. PubMed ID: 34896404
[TBL] [Abstract][Full Text] [Related]
4. Roles of the gut virome and mycobiome in faecal microbiota transplantation.
Lam S; Bai X; Shkoporov AN; Park H; Wu X; Lan P; Zuo T
Lancet Gastroenterol Hepatol; 2022 May; 7(5):472-484. PubMed ID: 35276080
[TBL] [Abstract][Full Text] [Related]
5. Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.
Niu C; Tu Y; Jin Q; Chen Z; Yuan K; Wang M; Zhang P; Luo J; Li H; Yang Y; Liu X; Mao M; Dong T; Tan W; Hu X; Pan Y; Hou L; Ma R; Huang Z
Front Cell Infect Microbiol; 2023; 13():1157368. PubMed ID: 37180439
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
Yadav A; Yadav R; Sharma V; Dutta U
Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
[TBL] [Abstract][Full Text] [Related]
7. Roles for the mycobiome in liver disease.
Zeng S; Schnabl B
Liver Int; 2022 Apr; 42(4):729-741. PubMed ID: 34995410
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension.
Chen BY; Lin WZ; Li YL; Bi C; Du LJ; Liu Y; Zhou LJ; Liu T; Xu S; Shi CJ; Zhu H; Wang YL; Sun JY; Liu Y; Zhang WC; Zhang Z; Zhang HL; Zhu YQ; Duan SZ
Microbiol Spectr; 2023 Feb; 11(1):e0195622. PubMed ID: 36475759
[TBL] [Abstract][Full Text] [Related]
9. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly.
Zhang F; Aschenbrenner D; Yoo JY; Zuo T
Lancet Microbe; 2022 Dec; 3(12):e969-e983. PubMed ID: 36182668
[TBL] [Abstract][Full Text] [Related]
10. Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives.
Fotis D; Liu J; Dalamaga M
Metabol Open; 2022 Jun; 14():100178. PubMed ID: 35308892
[TBL] [Abstract][Full Text] [Related]
11. A genomic compendium of cultivated human gut fungi characterizes the gut mycobiome and its relevance to common diseases.
Yan Q; Li S; Yan Q; Huo X; Wang C; Wang X; Sun Y; Zhao W; Yu Z; Zhang Y; Guo R; Lv Q; He X; Yao C; Li Z; Chen F; Ji Q; Zhang A; Jin H; Wang G; Feng X; Feng L; Wu F; Ning J; Deng S; An Y; Guo DA; Martin FM; Ma X
Cell; 2024 Jun; 187(12):2969-2989.e24. PubMed ID: 38776919
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics.
Li L; Huang X; Chen H
Gut Microbes; 2024; 16(1):2328868. PubMed ID: 38485702
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of the gut mycobiome in liver diseases.
Szóstak N; Figlerowicz M; Philips A
Gut Microbes; 2023; 15(1):2211922. PubMed ID: 37184158
[TBL] [Abstract][Full Text] [Related]
14. Expansion of Opportunistic Enteric Fungal Pathogens and Occurrence of Gut Inflammation in Human Liver Echinococcosis.
Wang Y; Guo A; Liu Z; Zou Y; Zhu W; Wu S; Zhang S; Guo X; Zhang S; Pu L; Zhu XQ; Zhu G; Cai X; Wang S
Microbiol Spectr; 2022 Oct; 10(5):e0145322. PubMed ID: 36098525
[TBL] [Abstract][Full Text] [Related]
15. The gut mycobiome of the Human Microbiome Project healthy cohort.
Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
[TBL] [Abstract][Full Text] [Related]
16. Host Factors Associated with Gut Mycobiome Structure.
Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
[TBL] [Abstract][Full Text] [Related]
17. Characterizations of the Gut Bacteriome, Mycobiome, and Virome in Patients with Osteoarthritis.
Chen C; Zhang Y; Yao X; Li S; Wang G; Huang Y; Yang Y; Zhang A; Liu C; Zhu D; Li H; Yan Q; Ma W
Microbiol Spectr; 2023 Feb; 11(1):e0171122. PubMed ID: 36515546
[TBL] [Abstract][Full Text] [Related]
18. Mycobiome in the Gut: A Multiperspective Review.
Chin VK; Yong VC; Chong PP; Amin Nordin S; Basir R; Abdullah M
Mediators Inflamm; 2020; 2020():9560684. PubMed ID: 32322167
[TBL] [Abstract][Full Text] [Related]
19. The gut mycobiome: a novel player in chronic liver diseases.
Jiang L; Stärkel P; Fan JG; Fouts DE; Bacher P; Schnabl B
J Gastroenterol; 2021 Jan; 56(1):1-11. PubMed ID: 33151407
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
